The sweeter side of ACE2: Physiological evidence for a role in diabetes
- 1 October 2008
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 302 (2), 193-202
- https://doi.org/10.1016/j.mce.2008.09.020
Abstract
No abstract availableKeywords
This publication has 159 references indexed in Scilit:
- The discovery of angiotensin‐converting enzyme 2 and its role in acute lung injury in miceExperimental Physiology, 2008
- Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosisJournal of Hepatology, 2007
- The physiology of a local renin–angiotensin system in the pancreasThe Journal of Physiology, 2007
- Expression of isoforms of NADPH oxidase components in rat pancreatic isletsLife Sciences, 2006
- Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on β-cell function and morphology in db/db miceBiochemical and Biophysical Research Communications, 2006
- Vascular adrenergic tone and structural narrowing constrain reactive hyperemia in skeletal muscle of obese Zucker ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonistBiochemical and Biophysical Research Communications, 2005
- The global spread of type 2 diabetes mellitus in children and adolescentsThe Journal of Pediatrics, 2005
- Sulfonylurea as well as elevated glucose levels stimulate reactive oxygen species production in the pancreatic β-cell line, MIN6—a role of NAD(P)H oxidase in β-cellsBiochemical and Biophysical Research Communications, 2004
- Distributed control of glucose uptake by working muscles of conscious mice: roles of transport and phosphorylationAmerican Journal of Physiology-Endocrinology and Metabolism, 2004